李寧(02331.HK)續升逾7%跑贏同業 獲多間大行維持正面評級
李寧(02331.HK)繼上周五獲GIC斥資近2億元趁低增持股權至5.11%後,公司CEO於投資會議上堅決肯定渠道庫存健康及減少出貨為優先措施,大摩指可能提振市場情緒,維寺「增持」評級看51元,高盛及瑞銀也重申李寧「買入」評級,分別看41元及39元。
李寧股價由低位連升第三天兼重越10天線(26.6元),最高見27.9元,現報27.75元,續升7.4%,成交增至3,073萬股。
同業股價今天僅續升逾1%-3%,獲匯豐研究偏愛的藍籌安踏(02020.HK)三連升兼重越10天及20天線,最高見91.9元,現報91.55元,續升3.2%。
恆指午後升幅擴大,最高見17,729,現報17,671,續升440點或近2.6%,總成交額718億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.